Sera Prognostics, Inc. Class A Common Stock
Symbol: SERA (NASDAQ)
0.00
▼ (-100.00%) -3.070
Company Description:
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $3.07
- Yesterday High: $3.2999
- Yesterday Low: $3.04
- Yesterday Volume: 94.14K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Sera Prognostics, Inc. Class A Common Stock
- Website: https://www.seraprognostics.com
- Listed Date: 2021-07-15
- Location: SALT LAKE CITY, UT
- Market Status: Active
- CIK Number: 0001534969
- SIC Code: 8071
- SIC description: SERVICES-MEDICAL LABORATORIES
- Market Cap: $116.85M
- Round Lot: 100
- Outstanding Shares: 38.06M
- Asset Type: CS
RECENT FILINGS FOR SERA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 4 | View |
| 2025-09-09 | 4 | View |
| 2025-09-09 | 144 | View |
| 2025-09-09 | 144 | View |
| 2025-09-09 | 4 | View |
| 2025-09-09 | 4 | View |
| 2025-09-09 | 144 | View |
| 2025-09-09 | 144 | View |
| 2025-09-08 | SCHEDULE 13G | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 144 | View |
| 2025-09-05 | 8-K | View |
| 2025-09-03 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-09-02 | 4 | View |
| 2025-08-29 | 144 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 144 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-11 | 4 | View |
Latest News on SERA